The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Practical Ways to Achieve Targets in Diabetes Care

I. Hirsch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Tirzepatide Updates

Diana Isaacs

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer…

Ken Fujioka

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

SAD and MAC Scores: How Does It Affects Outcomes

NY Endovascular Summit

S. Kum

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Pedal Acceleration Time in PAD Evaluation

UPMC

M. Madigan

The Role of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Pediatr…

ISPAD's 50th Annual Conference 2024

A. Sanghavi

Wegovy 2024 Updates

Susan Brian

Difficult-to-Treat Type 2 Diabetes – Could Hypercortisolism be the E…

Endocrinology 2024 Year in Review

Type 2 Diabetes Aetiology and Reversibility

Jason Fung

BEST CLI Debate: Endovascular Will Still Be First Line Treatment & P…

Transformative Endovascular Decisions Conference

P. Soukas